World Vaccine Congress Asia brings new scientific and business critical debate, discussion and solutions from the true global pioneers shaping vaccine R&D
 

World Vaccine Congress Asia 2012
(全球疫苗學會:亞洲、2012年)
2012年6月11-14日 | 新加坡

是能與業界領導人交換意見的寶貴機會

World Vaccine Congress Asia中,在疫苗研究開發領域領導全球的大人物齊聚一堂,針對研究領域和事業領域新的重要課題展開熱烈的討論,並尋求解決方法。

能聆聽相關各公司主管們的意見,與在此業界負起重要作用者商談或深入交往的此學會,是為對全球疫苗團體有很大影響力、負起將來發展的領導者舉行的會議。

  • 在2天的學會和1日的研究會中,有100人以上的演講者登場
  • 預定有90場以上的會議,連續40小時進行充實的討論
  • 預定進行20小時以上為了建構人際關係的活動

Sponsors

Platinum sponsor
GE Healthcare at World Vaccine Congress Asia 2012
Bronze sponsor
Finesse Solutions LLC at World Vaccine Congress Asia 2012
Innovative showcase sponsor
Bavarian Nordic A/S at World Vaccine Congress Asia 2012

 
 

在World Vaccine Congress Asia 2012中

  • 能學習進入新市場的方法
  • 能學習強化製造能力的方法
  • 能學習與在亞洲各國展開事業的臨床試驗外包機關建構策略性合作關係的方法
  • 能學習與以各種水平開發疫苗的亞洲生物技術企業建構合作關係的方法
  • 能學習以因應熱帶病和亞洲地區地方病的疫苗共同開發作為目的,使合作成功的方法

能獲得有助於擴大事業的優異構思。

World Vaccine Congress Asia 2012的主要主題
 

  • 公共醫療制度的改革、法規整備、預防接種
  • 設定國家級疫苗計劃的優先順序
  • 因應全球新市場的需求
  • 進入全球規模市場的策略
  • 亞洲流行性感冒疫苗事業的發展
  • 研究開發、合作、投資
  • 亞洲地區防止全國大流行和感染性疾病的策略

是不容錯過能獲知該領域技術創新最新動向的學會。
 

全球最高層疫苗解決方案提供商參加此學會的理由

  • 為了向來自亞洲各國各公司高階主管宣傳自家公司的品牌
  • 為了提高是業界銷售龍頭的知名度
  • 為了獲得鎖定的顧客等與參加費用有相乘效果的好處
  • 為了進入亞洲有前景的疫苗市場
  • 為了與在亞洲地區展開事業的企業高階主管建構人際關係

是今年舉行的活動中,為促進行銷和事業開發最重要的學會。
 

推薦參加的5個理由

  • 集合在疫苗業界的關聯企業和團體等總括產品部門和事業部門的500人以上高階主管
  • 策略、研究開發、臨床、製造、細胞培養等超過專業的100人最高負責人級與副社長級進行演講
  • 舉行為了研究發表的專門論壇,由40人以上的研究人員進行海報會議
  • 網羅全部疫苗價值鏈的4個學會在一樣的會場舉行
World Vaccines Congress is al meeting of vaccine buyers and sellers, NGOs, health authorities, regulators, vaccine  and other stakeholders in Asia!
 

World Vaccine Congress Asia的主要特徵

  • 能聆聽聽業界有關人員說明實際體驗的資訊: 行政機關、製藥公司、生物技術關係的演講者佔全部的85%,能期待有個充實的議論
  • 質和量都充實的學會: 是由重點演講、個案研究、專題討論會、各種部會等100場以上的會議構成的綜合性計畫,能因應事業面的各種需求
  • 能遇到企業和團體的上級負責主管: 製造商、品牌、事業部門、管道等的負責人將大量參加
  • 是全球規模的學會: 預定有來自30個以上國家的參加者,網羅全部主要的地區和大陸
  • 是超過20小時的社交活動:與在業界內擔任指導作用者建構人際關係
 

 Limited speaking opportunities available for leading solutin providers

World Vaccine Trials Congress Asia 2012 is about Advancing vaccine clinical development in Asia for pharmas, biotechs and partners

World Vaccine Trials Congress Asia 2012

Advancing vaccine clinical development in Asia for pharmas, biotechs and partners

Advance your clinical trials effectively and efficiently and overcome the biggest hurdle to placing your vaccine candidate on the market.

Learn how to:

  • Leverage on Asia’s clinical research capabilities to reduce R&D cost for vaccines
  • Access a wider patient pool in Asia for trials for both adult and pediatric vaccines
  • Navigate around regulatory complexities in conducting vaccine clinical trials in Asia
  • Develop successful strategies in conducting vaccine clinical trial that are cost effectively and efficiently in Asia
  • Identify and meet suitable CROs and other partners that have specialty in handling vaccines
  • Identify the most suitable site locations to conduct vaccine trials in Asia

You’ll come away with great new ideas to do better business.
 

World Vaccine Manufacturing Congress Asia 2012 is about Manufacturing innovation for Pharma, Biotechs and Partners 

World Vaccine Manufacturing Congress Asia 2012

Adopt production capabilities and establish robust and efficient manufacturing processes for vaccine development and manufacturing advances.

Learn how to:

  • Reduce Drug manufacturing cost for vaccines
  • Outsource vaccine manufacturing but maintaining quality
  • Find the right partners either globally or in Asia that meets their needs and standards
  • Ensure intellectual property protection while outsourcing to third parties
  • Ensure regulatory compliance for Asia markets and to address the global concerns on quality, reliability and authenticity
  • Ensure manufacturing plants receive Asian regulatory  approval for exports
  • Integrate the latest and advanced technological solutions
  • Increase competitive edge against competition
  • Expand their business internationally to cover the international market
  • Increase customer base
  • Meet potential partners

You’ll come away with great new ideas to do better business.

World Vaccine Partnering Congress Asia 2012 is about Innovation, licensing, and partnership opportunities for pharmas, biotechs, and partners 

World Vaccine Partnering Congress Asia 2012

Advance vaccine development effectively with innovation, partnering and discovery opportunities.

Learn how to:

  • Scout for potential biotechs or pharmas to acquire or collaborate with
  • Establish industry leadership and strengthen branding in the region
  • Educate and attract the industry on how you could possibly work with them through collaboration, licensing or M&A
  • Source for funding from pharmas and investors
  • Develop a successful strategy for pipelines from R&D to commercialization
  • Find partners to accelerate commercialization
  • Find biotechs or pharmas with highest ROIs
  • Manage risks in investing in start-ups to mid size companies

Come away with new ideas and new strategies to do better business.
 

  
Sponsors
Platinum sponsor
GE Healthcare at World Vaccine Congress Asia 2012
Bronze sponsor
Finesse Solutions LLC at World Vaccine Congress Asia 2012
Innovative showcase sponsor
Bavarian Nordic A/S at World Vaccine Congress Asia 2012